Navigation Links
Avastin Added to Chemo Helps Women With Advanced Cancer
Date:5/31/2008

stin is the current standard dose for breast cancer treatment, while the higher dose is the standard dose for colon cancer.

After a median follow-up of almost one year, women taking the lower dose of Avastin were 21 percent less likely and those taking the higher dose 28 percent less likely to have a recurrence compared to those receiving chemo alone. More than half (55.2 percent) in the low-dose group and two-thirds (63.3 percent) in the high-dose group saw their tumors shrink, compared to 44.4 percent in the placebo group.

Patients receiving Avastin did have more severe side effects (74 percent to 75 percent versus 67 percent in the chemotherapy-alone group).

Final data on overall survival is not yet available. According to Dr. Eric Weiner, director of the breast oncology center at Dana-Farber Cancer Institute in Boston and moderator of the Saturday news conference, "it is unlikely there will be a survival benefit."

The U.S. Food and Drug Administration tends to approve second and third-line drugs based on progression-free survival and drugs for the first-line setting on survival, Weiner said, adding that he "personally does not understand that approach."

Progression-free survival can be seen as a quality-of-life improvement. "Having the disease under control for longer, as long as the toxicity of treatment is not substantial, is something that is well worth it," Weiner said. "So a drug that can substantially improve profession-free survival is a drug that can at least, in some patients, make their lives that much better while they are dealing with this illness."

More information

The American Society of Clinical Oncology has more information on breast cancer.



SOURCES: May 31, 2008, news conference with Eric Weiner, M.D., director, breast oncology center, Dana-Fa
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Off-Label Avastin Use for Wet Macular Degeneration
2. FDA OKs Avastin for Advanced Breast Cancer
3. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
4. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
5. Many More Patients Can Now Benefit from Avastins Proven Survival Benefits
6. Taxol with avastin produces noteworthy results
7. FDA Panel Says No to Avastin for Advanced Breast Cancer
8. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
9. IPC The Hospitalist Company Added to Russell 2000 Index
10. Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRALs(R) Live On-air Charity Special Night of Too Many Stars: An Overbooked Concert for Autism Education Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
11. Turner Investment Partners Added to AHA Diversified Equity Fund
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avastin Added to Chemo Helps Women With Advanced Cancer
(Date:8/1/2014)... Tara Haelle HealthDay ... A home-packed lunch isn,t necessarily healthier than school cafeteria fare, ... just 27 percent of the lunches third and fourth graders ... Program (NSLP) standards. , , "Our findings are similar to ... the world, which have found that high-calorie packaged foods and ...
(Date:8/1/2014)... [Brown University] New research shows that people who ... incarcerated have a 16-percent greater risk of experiencing poor ... family member sent to prison. The finding, which accounted ... nation,s high rate of imprisonment may be independently imparting ... , "These people were children when this happened, and ...
(Date:8/1/2014)... Fresh from Las Vegas market, the team at ... exciting products. With the 2014 Holiday season just around the ... new products. There have already been some exciting new releases, ... brands like Cozzia and Inada will be making a big ... takes place two times a year and is a great ...
(Date:8/1/2014)... 2014 The Multiple System Atrophy Coalition, a ... caregivers and families affected by the neurological disorder Multiple System ... La Coste, TX to its Board of Directors. , Sharon ... Eric Sutton. He was diagnosed officially with MSA in 2010 ... his family. Like many others with this rare disorder it ...
(Date:8/1/2014)... Fitness is something most people can add to ... the block to biking ten or more miles, adding daily ... throughout the year. The Forbes Living talk show ... feature special guests, tips to get started and cool products ... will air on most popular cable television networks. , ...
Breaking Medicine News(10 mins):Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 2Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 3Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Forbes Living to Air Fitness Forward Series 2
... This release is available in ... scientist Dr. Timothy Geary received a $1-million grant today ... derived from African biodiversity. Grand Challenges Canada, Canada,s ... Research and the Bill & Melinda Gates Foundation have ...
... University of Michigan Cardiovascular Center and the University of Pittsburgh ... of heart devices for the large and growing group of ... Lung and Blood Institute and HeartWare International, a maker of ... access to these devices that support the circulation of patients ...
... breast cancer medication, may reduce an individual,s risk of death ... a peer-reviewed journal of the American Cancer Society, the study ... lung cancer and that estrogen levels play a role in ... menopausal hormone therapy increases women,s risk of dying from lung ...
... to survive and thrive in its hiding spot within the human ... HIV remains such a formidable foe after three decades of research ... it also offers scientists a new, unexpected way to try ... University of Rochester Medical Center and Emory University was published Dec. ...
... at Johns Hopkins have deciphered the genetic code for a ... The work, described online in the Jan. 20 issue of ... certain coding "mistakes" live twice as long as those without ... is that each patient with this kind of rare cancer ...
... HealthDay Reporter , FRIDAY, Jan. 21 (HealthDay News) ... Drug Administration approve a new chemical that can highlight the ... help doctors diagnose the neurodegenerative disease, experts said Friday. ... 0 to recommend approval of the imaging agent, known as ...
Cached Medicine News:Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 3Health News:Anti-estrogen medication reduces risk of dying from lung cancer 2Health News:Unexpected find opens up new front in effort to stop HIV 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3Health News:Alzheimer's Scan Might Help Spot Disease 2Health News:Alzheimer's Scan Might Help Spot Disease 3
(Date:8/1/2014)... 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research ... and "2014 Deep Research Report on Global and ... research database. Photo - ... Report on Global and China Potassium Nitrate  Industry" ... China and Global Potassium ...
(Date:7/31/2014)... July 31, 2014 STAAR Surgical Company (NASDAQ: ... marketer of implantable lenses and delivery systems for the ... July 4, 2014 of $20.0 million, a 10% increase ... 2013. On a constant currency basis, revenues grew 11% ... second quarter of 2013.  The effect of foreign currency ...
(Date:7/31/2014)... Calif., July 31, 2014 Xencor Inc. ... company developing engineered monoclonal antibodies for the treatment ... cancer, today reported financial results for the second ... of recent business highlights. "In the ... American Thoracic Society 2014 International Conference (ATS) demonstrating ...
Breaking Medicine Technology:Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Xencor Reports Second Quarter 2014 Financial Results 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: